πŸ‡ΊπŸ‡Έ FDA
Patent

US 7825102

Treatment of dry eye conditions

granted A61KA61K31/52A61K31/7076

Quick answer

US patent 7825102 (Treatment of dry eye conditions) held by CAN-FITE BIOPHARMA LTD. expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAN-FITE BIOPHARMA LTD.
Grant date
Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/52, A61K31/7076, A61P, A61P27/04